Nearly two dozen students from Lancaster County who are pursuing careers in mental health have been awarded scholarships or fellowships from The Steinman Foundation and Touchstone Foundation.
Triplet therapy for advanced renal cell carcinoma may soon be an option, after results show that adding cabozantinib to dual immune checkpoint inhibition improved progression-free survival.
Six months of adjuvant nivolumab plus ipilimumab after nephrectomy for renal cell carcinoma offers no disease-free survival benefit, reveals trial that highlights treatment duration and tolerability.